Na tej stronie
01ZBH cena
02Zrzut ekranu
03Wykres
04Podziały akcji
05O nas
06Wyniki
07Wycena i wskaźniki
13Dywidendy
14Zyski
15Pełne podstawowe wskaźniki
16Sprawozdania
17Właściciele instytucjonalni (13F)
18Aktywiści i właściciele 5%+
19Insiderzy spółki
20Posiadanie ETF-ów
21Konsensus
22Równi
23Wiadomości
25Sygnały transakcyjne
26Moje wskaźniki
ZBH Zimmer Biomet Holdings, Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 5, 2026 10-K/10-Q Sie 5, 2026
$91,57
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$79,1252tyg. minimum
$106,8852tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$29.25B
P/E (TTM)
22.2
EPS (TTM)
$4.12
Przychody (TTM)
$8.51B
Twoje odznaki
Zakres 52 tyg.
$79–$107
Ocena Analityków
HOLD
Cena Docelowa
$108
P/E
22.2
ROE
6.4%
Marża Zysku Netto
9.5%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
ZBH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$91.57
Kapitalizacja Rynkowa (MRQ)
$29.25B
P/E (TTM)
22.2
EPS (TTM)
$4.12
Przychody (TTM)
$8.51B
Stopa dywidendy
0.65%
ROE (TTM)
6.4%
D/E Dług/Kapitał (MRQ)
0.6
Zakres 52 tyg.
$79–$107
ZBH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 1 marca 2022 | 103-for-100 | Naprzód |
O Zimmer Biomet Holdings, Inc. Common Stock Przegląd firmy z Wikipedii
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.
History
Zimmer Biomet was established in 1927 by Justin O. Zimmer (1884–1951) in Warsaw, Indiana.
On April 24, 2014, it was announced that Zimmer had agreed to purchase Biomet Inc. for $13.4 billion. In October 2014, however, it was announced that the EU's antitrust regulators had opened an extensive investigation into Zimmer's bid for Biomet due to concern that it would substantially lessen competition in certain markets. In March 2016, European Commission (“EC”) conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. and on June 24, 2015, Zimmer completed its acquisition of Biomet forming Zimmer Biomet Holdings.
In October 2014, the company announced it would acquire ETEX Holdings, Inc.
In March 2016, Zimmer Biomet announced it would acquire Ortho Transmission, LLC. The company also announced it would acquire sports medicine company, Cayenne Medical, Inc. Later in the same year the company acquired medical device manufacturer, LDR Holding Corporation for $37 per share ($1 billion in total), merging it into their Spine division. In July, the company acquired French surgical robotics company Medtech. In August, the company announced it was acquiring Delaware-based CD Diagnostics, a diagnostics company developing immunoassays and biomarker testing. In September, Zimmer announced the acquisition of Clinical Graphics, B.V.
The Justin Zimmer House in Warsaw is listed on the National Register of Historic Places.
In January 2023, the company announced its intention to acquire Embody, Inc. for $155 million (plus a potential $120 million in milestones).
In August 2024, Zimmer Biomet announced plans to acquire OrthoGrid Systems, an AI surgical guidance company, in order to expand its market share in hip replacement procedures.
In 2026, Zimmer Biomet acquired the iovera pain therapy business from Pacira BioSciences Inc. for $140 million.
Products
Zimmer designs, develops, manufactures and markets orthopedics products, including knee, hip, shoulder, elbow, foot and ankle artificial joints and dental prostheses. In 2024, Zimmer introduced the ROSA Shoulder, said to be the world's first robotic surgery system for shoulder replacement, and the fourth application for the company's ROSA Robotics portfolio, which includes the ROSA Knee System for total knee arthroplasty and ROSA Hip System for total hip replacement. Zimmer has operations in more than 40 countries around the world (US, Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Latin America, Netherlands, Brasil, Poland, Portugal, Russia, South Africa, Spain etc.) and sells products in more than 100 countries.
Acquisition history
The following is an illustration of the company's major mergers, acquisitions and historical predecessors:
Company data
Zimmer's 2023 sales were approximately $7.4 billion. The company has approximately 18,000 employees worldwide.
Leadership
Raymond Elliott was president and CEO from August 2001 to May 2007.
David C. Dvorak, was president and CEO from May 1, 2007, to July 11, 2017.
Dan Florin, Interim President and CEO from July 11, 2017, to December 19, 2017.
Bryan C. Hanson, President and CEO from December 19, 2017 to August 22, 2023.
Ivan Tornos, President and CEO from August 22, 2023, to present.
Recognition
In 2016, the company was recognized on the Fortune 500 list for the first time, ranking in position #431. As of 2026, the company is ranked 463rd on the list.
Criticism
During the 2022 Russian invasion of Ukraine, Zimmer Biomet continued to sell to the Russian market. Research from Yale University updated on April 28, 2022, identifying how companies were reacting to Russia's invasion identified Zimmer Biomet as continuing business-as-usual in Russia: companies defying demands for exit/reduction of activities.
Public-private engagement
Activism
Zimmer Biomet is a corporate partner of Human Rights Campaign, a large LGBT advocacy organization.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy17 000
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$8.23B2016-12-31 → 2025-12-31
EPS$3.552016-12-31 → 2025-12-31
Wolny przepływ pieniężny$1.47B2016-12-31 → 2025-12-31
Marża netto9.5%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ZBH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 22.2średnia z 5 lat ≈50.9 | ≈50.9 | 28.6 | Niedowartościowany | |
| P/S (TTM) | 3.4średnia z 5 lat ≈4.9 | ≈4.9 | 4.4 | Niedowartościowany | |
| P/B (MRQ) | 2.3średnia z 5 lat ≈2.9 | ≈2.9 | 4.7 | Niedowartościowany | |
| EV / EBITDA | 16.5średnia z 5 lat ≈21.1 | ≈21.1 | 17.3 | Niedowartościowany | |
| Cena / FCF (TTM) | 19.2średnia z 5 lat ≈27.7 | ≈27.7 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 16.8średnia z 5 lat ≈23.8 | ≈23.8 | 21.9 | Niedowartościowany | |
| EV / Revenue (EV / Przychody) | 4.4średnia z 5 lat ≈5.7 | ≈5.7 | · | · | |
| EV / FCF | 24.6średnia z 5 lat ≈32.2 | ≈32.2 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 3.6 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ZBH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 14.2%średnia z 5 lat ≈13.5% | ≈13.5% | 15.6% | Zgodnie z | |
| Marża EBITDA (TTM) | 27.2%średnia z 5 lat ≈26.7% | ≈26.7% | 15.6% | Zgodnie z | |
| Marża przed opodatkowaniem (TTM) | 11.0%średnia z 5 lat ≈9.8% | ≈9.8% | 14.0% | Słaby | |
| Marża Zysku Netto (TTM) | 9.5%średnia z 5 lat ≈8.5% | ≈8.5% | 11.2% | Słaby | |
| ROA (TTM) | 3.5%średnia z 5 lat ≈3.0% | ≈3.0% | 8.0% | Słaby | |
| ROE (TTM) | 6.4%średnia z 5 lat ≈5.3% | ≈5.3% | 14.8% | Słaby | |
| ROIC | 4.6%średnia z 5 lat ≈4.8% | ≈4.8% | 10.9% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ZBH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.6średnia z 5 lat ≈0.5 | ≈0.5 | 0.2 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 1.7średnia z 5 lat ≈1.8 | ≈1.8 | 1.8 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.9średnia z 5 lat ≈0.7 | ≈0.7 | 0.9 | Niska płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.5średnia z 5 lat ≈0.4 | ≈0.4 | 0.5 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ZBH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 7.2%średnia z 5 lat ≈6.1% | ≈6.1% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 5.9%średnia z 5 lat ≈5.4% | ≈5.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 6.1% | · | · | · | |
| EPS YoY | -19.9%średnia z 5 lat ≈68.0% | ≈68.0% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -22.0%średnia z 5 lat ≈66.6% | ≈66.6% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 47.8% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 45.0% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ZBH | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.4średnia z 5 lat ≈0.3 | ≈0.3 | 0.6 | Słaby | |
| Inventory Turnover (Rotacja zapasów) | 1.1średnia z 5 lat ≈1.0 | ≈1.0 | 2.4 | Słaby | |
| Receivables Turnover (Rotacja należności) | 5.2średnia z 5 lat ≈5.3 | ≈5.3 | 6.2 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$484.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.65%
Wskaźnik Wypłaty Dywidendy27.0%
Zannualizowane wypłaty≈$0.96
CAGR dywidendy 5-letni≈0.59%
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 30, 2026 | $0,24 | USD | ≈1.1% |
| Cze 25, 2026 | $0,24 | USD | ≈1.1% |
| Mar 31, 2026 | $0,24 | USD | ≈1.1% |
| Gru 30, 2025 | $0,24 | USD | ≈1.1% |
| Wrz 30, 2025 | $0,24 | USD | ≈0.97% |
| Cze 26, 2025 | $0,24 | USD | ≈1.0% |
| Mar 31, 2025 | $0,24 | USD | ≈0.85% |
| Gru 30, 2024 | $0,24 | USD | ≈0.91% |
| Wrz 30, 2024 | $0,24 | USD | ≈0.89% |
| Cze 26, 2024 | $0,24 | USD | ≈0.89% |
| Mar 27, 2024 | $0,24 | USD | ≈0.72% |
| Gru 26, 2023 | $0,24 | USD | ≈0.79% |
| Wrz 28, 2023 | $0,24 | USD | ≈0.85% |
| Cze 23, 2023 | $0,24 | USD | ≈0.67% |
| Mar 28, 2023 | $0,24 | USD | ≈0.76% |
| Gru 23, 2022 | $0,24 | USD | ≈0.76% |
| Wrz 29, 2022 | $0,24 | USD | ≈0.89% |
| Cze 24, 2022 | $0,24 | USD | ≈0.87% |
| Mar 28, 2022 | $0,24 | USD | ≈0.75% |
| Gru 27, 2021 | $0,23 | USD | ≈0.75% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
3.0%
Następny raport
Lis 03, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 5, 2026 | $2.07 | $2.03 | 2.0% |
| 31 marca 2026 | $2.09 | $1.88 | 11.0% | |
| 31 grudnia 2025 | $2.42 | $2.42 | 0.00% | |
| 30 września 2025 | $1.90 | $1.89 | 0.73% | |
| 30 czerwca 2025 | $2.07 | $2.00 | 3.3% | |
| 31 marca 2025 | $1.81 | $1.79 | 1.2% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Cost of Revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.80B | $1.24B | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $3.42B | |
| SG&A Expense | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.10B | $2.94B | $2.28B | $1.75B | |
| Operating Expenses | $7.13B | $6.39B | $6.12B | $6.24B | $5.97B | $6.04B | $6.84B | $7.90B | $7.00B | $6.85B | $5.53B | $3.64B | |
| Operating Income | $1.10B | $1.29B | $1.28B | $696M | $860M | $83M | $1.14B | $34M | $799M | $821M | $467M | $1.04B | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $3M | $9M | $12M | |
| Other Non-op | $26M | $-31M | $-9M | $-128M | $12M | $24M | $-5M | $-16M | $-9M | $-66M | $-37M | $-47M | |
| Pretax Income | $831M | $1.04B | $1.07B | $404M | $499M | $-105M | $906M | $-271M | $465M | $400M | $153M | $939M | |
| Income Tax | $126M | $131M | $42M | $112M | $54M | $-96M | $-226M | $108M | $-1.35B | $95M | $7M | $220M | |
| Net Income | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | $-0.67 | $5.52 | $-1.86 | $8.98 | $1.53 | $0.78 | $4.26 | |
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 | |
| Shares (Basic) | 198,000,000 | 203,100,000 | 208,700,000 | 209,600,000 | 208,600,000 | 207,000,000 | 205,100,000 | 203,500,000 | 201,900,000 | 200,000,000 | 187,400,000 | 169,000,000 | |
| Shares (Diluted) | 198,700,000 | 203,900,000 | 209,700,000 | 210,300,000 | 210,400,000 | 207,000,000 | 206,700,000 | 203,500,000 | 203,700,000 | 202,400,000 | 189,800,000 | 171,700,000 | |
| EBITDA | $2.19B | $2.28B | $2.23B | $1.62B | $1.85B | $945M | $2.14B | $1.07B | $1.87B | $1.87B | $1.18B | $1.41B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $592M | $526M | $416M | $376M | $378M | $802M | $618M | $543M | $524M | $634M | $1.46B | $1.08B | |
| Receivables | $1.70B | $1.48B | $1.44B | $1.38B | $1.26B | $1.45B | $1.36B | $1.28B | $1.54B | $1.60B | $1.45B | $912M | |
| Inventory | $2.29B | $2.24B | $2.39B | $2.15B | $2.15B | $2.45B | $2.38B | $2.26B | $2.07B | $1.96B | $2.25B | $1.19B | |
| Prepaid Expense | $537M | $430M | $366M | $523M | $271M | $169M | $357M | $352M | $428M | $466M | $529M | $317M | |
| Current Assets | $5.12B | $4.67B | $4.61B | $4.43B | $4.88B | $5.08B | $4.72B | $4.43B | $4.56B | $4.66B | $5.85B | $4.31B | |
| PP&E (Net) | $2.21B | $2.05B | $2.06B | $1.87B | $1.84B | $2.05B | $2.08B | $2.02B | $2.04B | $2.04B | $2.06B | $1.29B | |
| PP&E (Gross) | $7.26B | $6.69B | $6.77B | $6.46B | $6.14B | $6.32B | $5.92B | $5.44B | $5.08B | $4.67B | $4.43B | $3.41B | |
| Accum. Depreciation | $5.05B | $4.64B | $4.71B | $4.59B | $4.30B | $4.28B | $3.84B | $3.42B | $3.05B | $2.63B | $2.37B | $2.12B | |
| Goodwill | $9.95B | $8.95B | $8.82B | $8.58B | $8.92B | $8.98B | $9.60B | $9.59B | $10.67B | $10.64B | $9.93B | $2.51B | |
| Intangibles | $4.72B | $4.60B | $4.86B | $5.06B | $5.53B | $7.06B | $7.26B | $7.68B | $8.35B | $8.79B | $8.75B | $604M | |
| Other Non-current Assets | $1.10B | $1.10B | $1.15B | $1.12B | $1.00B | $969M | $980M | $405M | $389M | $554M | $564M | $942M | |
| Total Assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Accounts Payable | $303M | $195M | $411M | $354M | $306M | $330M | $401M | $363M | $330M | $364M | $285M | $145M | |
| Accrued Liabilities | $834M | $706M | $804M | $582M | $536M | $873M | $778M | $671M | $775M | $789M | $726M | $351M | |
| Current Liabilities | $2.58B | $2.45B | $2.86B | $2.36B | $3.47B | $2.56B | $3.44B | $2.42B | $3.07B | $2.38B | $1.62B | $1.02B | |
| Capital Leases | $176M | $190M | $174M | $167M | $175M | $218M | $216M | · | · | · | · | · | |
| Deferred Tax | $244M | $352M | $358M | $475M | $558M | $790M | $840M | $1000M | $1.10B | $3.03B | $3.15B | $46M | |
| Other Non-current Liabilities | $626M | $744M | $926M | $633M | $548M | $656M | $558M | $350M | $446M | $463M | $1.01B | $611M | |
| Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B | $12.22B | $12.25B | $12.85B | $14.28B | $17.01B | $17.27B | $3.11B | |
| Long-term Debt | $7.52B | $6.20B | $5.77B | $5.70B | $1.00B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | · | · | |
| Total Debt | $7.52B | $6.20B | $5.77B | $5.70B | $7.07B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | $11.56B | $1.43B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $11.61B | $11.10B | $10.38B | $9.56B | $10.29B | $10.09B | $10.43B | $9.49B | $10.02B | $8.47B | $8.35B | $8.36B | |
| Treasury Stock | $8.89B | $8.41B | $7.56B | $6.87B | $6.72B | $6.72B | $6.72B | $6.72B | $6.72B | $6.74B | $6.33B | $6.18B | |
| AOCI | $-206M | $-263M | $-191M | $-179M | $-232M | $-298M | $-242M | $-187M | $-83M | $-434M | $-329M | $38M | |
| Stockholders' Equity | $12.70B | $12.47B | $12.48B | $12.02B | $12.66B | $12.19B | $12.39B | $11.27B | $11.74B | $9.67B | $9.89B | $6.55B | |
| Liabilities + Equity | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Shares Outstanding | 318,700,000 | 317,500,000 | 316,200,000 | 313,800,000 | 312,800,000 | 311,400,000 | 309,900,000 | 307,900,000 | 306,500,000 | 304,700,000 | 302,700,000 | 268,400,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.09B | $996M | $952M | $926M | $938M | $898M | $1.01B | $1.04B | $1.06B | $1.04B | $712M | $376M | |
| Stock-based Comp | $90M | $101M | $100M | $105M | $76M | $74M | $84M | $66M | $54M | $57M | $46M | $49M | |
| Deferred Tax | $-87M | $-48M | $-96M | $-64M | $-102M | $39M | $-539M | $13M | $-1.78B | $-153M | $-164M | $-90M | |
| Amort. of Intangibles | $666M | $592M | $562M | $527M | $530M | $512M | $584M | $596M | $604M | $566M | $337M | $92M | |
| Restructuring | · | · | · | · | $32M | · | · | · | $17M | $91M | $196M | · | |
| Other Non-cash | $-105M | $-454M | $-398M | $158M | $95M | $219M | $-98M | $1.01B | $428M | $383M | $75M | $-8M | |
| Operating Cash Flow | $1.70B | $1.50B | $1.58B | $1.36B | $1.40B | $1.08B | $1.59B | $1.75B | $1.58B | $1.63B | $850M | $1.06B | |
| CapEx | $224M | $204M | $291M | $188M | $144M | $112M | $207M | $163M | $156M | $185M | $168M | $145M | |
| Investing Cash Flow | $-1.98B | $-888M | $-779M | · | $-504M | $-614M | $-729M | $-417M | $-511M | $-1.69B | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $750M | $3.00B | · | |
| Net Debt Issued | · | · | · | · | · | · | · | $-1.43B | $-940M | $-50M | $2.50B | · | |
| Stock Repurchased | $487M | $868M | $692M | $126M | · | · | · | · | · | $416M | $150M | $401M | |
| Net Stock Activity | $-487M | $-868M | $-692M | $-126M | · | · | · | · | · | $-416M | $-150M | $-400M | |
| Dividends Paid | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M | |
| Financing Cash Flow | $326M | $-484M | $-764M | · | $-1.31B | $-422M | $-780M | $-1.30B | $-1.21B | $-743M | · | · | |
| Net Change in Cash | $66M | $110M | $40M | $-103M | $-324M | $184M | $75M | $18M | $-110M | $-825M | $376M | $3M | |
| Taxes Paid | $377M | $328M | $215M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B | $1.09B | $1.38B | $1.58B | $1.43B | $1.45B | $649M | $908M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 73.3% | |
| Operating Margin | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% | -1.2% | 14.2% | 0.43% | 10.3% | 10.8% | 7.8% | 22.1% | |
| Net Margin | 8.6% | 11.8% | 13.9% | 3.3% | 5.1% | -2.0% | 14.2% | -4.8% | 23.2% | 4.0% | 2.5% | 15.4% | |
| Pretax Margin | 10.1% | 13.5% | 14.4% | 5.8% | 5.3% | -3.9% | 11.3% | -3.4% | 5.9% | 5.2% | 2.5% | 20.2% | |
| EBITDA Margin | 26.6% | 29.7% | 30.1% | 23.4% | 23.6% | 13.5% | 26.9% | 13.5% | 23.9% | 24.3% | 19.7% | 30.2% | |
| ROA | 3.2% | 4.2% | 4.8% | 1.0% | 1.7% | -0.57% | 4.6% | -1.5% | 6.9% | 1.1% | 0.54% | 7.5% | |
| ROE | 5.6% | 7.2% | 8.4% | 1.9% | 3.2% | -1.1% | 9.6% | -3.3% | 17.0% | 3.1% | 1.5% | 11.2% | |
| ROIC | 4.6% | 6.0% | 6.7% | 2.8% | 3.8% | -0.22% | 6.9% | 0.23% | 14.4% | 3.0% | 2.1% | 9.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 | 2.0 | 1.4 | 1.8 | 1.5 | 2.0 | 3.6 | 4.1 | |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 | 0.9 | 0.6 | 0.8 | 0.7 | 0.9 | 1.8 | 1.9 | |
| Debt / Equity | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 1.2 | 0.2 | |
| LT Debt / Equity | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.8 | 1.1 | 1.2 | 0.2 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.5 | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.1 | 1.1 | 1.1 | 0.8 | 1.1 | |
| Receivables Turnover | 5.2 | 5.3 | 5.2 | 5.3 | 5.5 | 5.0 | 6.0 | 5.6 | 5.0 | 5.0 | 5.1 | 5.1 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.84 | $39.27 | $39.47 | $38.31 | $40.48 | $39.16 | $39.97 | $36.61 | $38.29 | $31.73 | $32.67 | · | |
| Revenue / Share | $41.43 | $37.66 | $35.26 | $33.00 | $37.24 | $33.93 | $38.62 | $38.98 | $38.41 | $37.96 | $31.60 | $27.22 | |
| Cash Flow / Share | $8.54 | $7.35 | $7.54 | $6.45 | $7.13 | $5.82 | $7.67 | $8.59 | $7.77 | $8.06 | $4.30 | $6.13 | |
| Cash / Share | $1.86 | $1.66 | $1.31 | $1.20 | $1.53 | $2.58 | $1.99 | $1.76 | $1.71 | $2.08 | $4.82 | · | |
| Dividend / Share | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.88 | $0.88 | |
| EPS (TTM) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.2% | 3.9% | 6.6% | 1.7% | 11.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.9% | 4.0% | 6.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.9% | -9.2% | 343.6% | -42.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 47.8% | 32.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -22.0% | -11.7% | 342.5% | -42.4% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 45.0% | 31.1% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -0.84% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Net Income TTM | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| Market Cap | $28.66B | $33.54B | $38.48B | $40.01B | $38.58B | $46.59B | $45.03B | $31.01B | $35.91B | $30.53B | $30.15B | · | |
| Enterprise Value | $35.58B | $39.22B | $43.83B | $45.33B | $45.17B | $53.91B | $52.64B | $39.40B | $45.53B | $41.14B | $40.25B | · | |
| P/E | 25.3 | 23.8 | 24.9 | 115.9 | 64.6 | -223.3 | 26.6 | -54.1 | 13.2 | 66.4 | 129.4 | 26.2 | |
| P/S | 3.5 | 4.4 | 5.2 | 5.8 | 5.7 | 7.6 | 5.6 | 3.9 | 4.6 | 4.0 | 5.0 | · | |
| P/B | 2.3 | 2.7 | 3.1 | 3.3 | 3.0 | 3.8 | 3.6 | 2.8 | 3.1 | 3.2 | 3.0 | · | |
| P / Cash Flow | 16.9 | 22.4 | 24.3 | 29.5 | 25.7 | 38.7 | 28.4 | 17.7 | 22.7 | 18.7 | 36.9 | · | |
| P / FCF | 19.5 | 25.9 | 29.8 | 34.2 | 29.1 | 42.9 | 32.7 | 19.6 | 25.2 | 21.1 | 46.5 | · | |
| EV / EBITDA | 16.2 | 17.2 | 19.7 | 27.9 | 24.4 | 57.1 | 24.6 | 36.7 | 24.3 | 22.1 | 34.1 | · | |
| EV / FCF | 24.2 | 30.3 | 34.0 | 38.8 | 34.0 | 49.6 | 38.2 | 24.9 | 31.9 | 28.4 | 62.0 | · | |
| EV / Revenue | 4.3 | 5.1 | 5.9 | 6.5 | 6.6 | 8.8 | 6.6 | 5.0 | 5.8 | 5.4 | 6.7 | · | |
| Dividend Yield | 0.66% | 0.58% | 0.52% | 0.50% | 0.52% | 0.43% | 0.44% | 0.63% | 0.54% | 0.62% | 0.52% | · | |
| Earnings Yield | 4.0% | 4.2% | 4.0% | 0.86% | 1.6% | -0.45% | 3.8% | -1.8% | 7.6% | 1.5% | 0.77% | 3.8% | |
| Payout Ratio | 27.0% | 21.7% | 19.6% | 87.0% | 49.8% | -142.9% | 17.4% | -51.5% | 10.7% | 61.6% | 106.9% | 20.2% | |
| Annual Payout | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.24B | $2.00B | $2.08B | $1.91B | $2.02B | $1.82B | $1.94B | $1.89B | $1.94B | $1.75B | $1.87B | $1.83B | $1.83B | $1.67B | |
| Cost of Revenue | $636M | $576M | $792M | $559M | $592M | $550M | $587M | $539M | $554M | $512M | $539M | $519M | $526M | $501M | $520M | $488M | |
| SG&A Expense | $899M | $850M | $872M | $811M | $815M | $759M | $747M | $710M | $737M | $736M | $722M | $675M | $726M | $716M | $727M | $655M | |
| Operating Expenses | $1.85B | $1.71B | $2.09B | $1.65B | $1.78B | $1.62B | $1.63B | $1.54B | $1.59B | $1.62B | $1.59B | $1.49B | $1.54B | $1.50B | $1.85B | $1.42B | |
| Operating Income | $326M | $373M | $154M | $351M | $300M | $292M | $389M | $280M | $351M | $266M | $354M | $267M | $330M | $327M | $-28M | $245M | |
| Other Non-op | $2M | $-3M | $15M | $3M | $4M | $3M | $-38M | $5M | $2M | $-100.0K | $-20M | $4M | $-1M | $8M | $-4M | $-25M | |
| Pretax Income | $255M | $301M | $98M | $279M | $225M | $229M | $289M | $230M | $302M | $215M | $284M | $219M | $277M | $287M | $-75M | $178M | |
| Income Tax | $56M | $63M | $-40M | $48M | $71M | $46M | $49M | $-19M | $59M | $42M | $-135M | $56M | $67M | $54M | $55M | $-17M | |
| Net Income | $198M | $238M | $139M | $231M | $153M | $182M | $240M | $249M | $243M | $172M | $419M | $163M | $210M | $232M | $-130M | $194M | |
| EPS (Basic) | $1.03 | $1.22 | $0.70 | $1.17 | $0.77 | $0.92 | $1.20 | $1.23 | $1.18 | $0.84 | $2.02 | $0.78 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| EPS (Diluted) | $1.03 | $1.22 | $0.71 | $1.16 | $0.77 | $0.91 | $1.18 | $1.23 | $1.18 | $0.84 | $2.00 | $0.77 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| Shares (Basic) | 192,200,000 | 195,000,000 | · | 198,100,000 | 197,900,000 | 198,900,000 | · | 202,300,000 | 205,700,000 | 205,200,000 | · | 208,900,000 | 208,600,000 | 209,400,000 | · | 209,800,000 | |
| Shares (Diluted) | 192,800,000 | 195,800,000 | · | 198,800,000 | 198,300,000 | 199,700,000 | · | 203,000,000 | 206,400,000 | 206,200,000 | · | 210,000,000 | 209,900,000 | 210,400,000 | · | 210,300,000 | |
| EBITDA | $326M | $643M | · | $351M | $300M | $547M | · | $280M | $351M | $504M | · | $267M | $330M | $559M | · | $245M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $410M | $424M | $592M | $1.29B | $557M | $1.38B | $526M | $569M | $420M | $393M | · | $292M | $320M | $330M | · | $545M | |
| Receivables | $1.77B | $1.73B | $1.70B | $1.60B | $1.61B | $1.53B | $1.48B | $1.48B | $1.42B | $1.45B | · | $1.34B | $1.37B | $1.38B | · | $1.28B | |
| Inventory | $2.27B | $2.25B | $2.29B | $2.48B | $2.45B | $2.24B | $2.24B | $2.37B | $2.37B | $2.39B | · | $2.32B | $2.28B | $2.24B | · | $2.13B | |
| Prepaid Expense | $647M | $563M | $537M | $460M | $431M | $428M | $430M | $445M | $431M | $404M | · | $416M | $425M | $460M | · | $347M | |
| Current Assets | $5.10B | $4.96B | $5.12B | $5.83B | $5.05B | $5.59B | $4.67B | $4.86B | $4.64B | $4.63B | · | $4.37B | $4.39B | $4.41B | · | $4.53B | |
| PP&E (Net) | $2.24B | $2.21B | $2.21B | $2.19B | $2.18B | $2.06B | $2.05B | $2.11B | $2.10B | $2.09B | · | $2.03B | $1.98B | $1.91B | · | $1.80B | |
| PP&E (Gross) | $7.42B | $7.30B | $7.26B | $7.22B | $7.15B | $6.82B | $6.69B | $6.90B | $6.74B | $6.85B | · | $6.65B | $6.72B | $6.59B | · | $6.34B | |
| Accum. Depreciation | $5.18B | $5.09B | $5.05B | $5.03B | $4.97B | $4.76B | $4.64B | $4.79B | $4.64B | $4.76B | · | $4.61B | $4.74B | $4.69B | · | $4.54B | |
| Goodwill | $9.92B | $9.93B | $9.95B | $9.70B | $9.71B | $8.99B | $8.95B | $8.91B | $8.82B | $8.79B | $8.82B | $8.71B | $8.74B | $8.73B | $8.58B | $8.80B | |
| Intangibles | $4.46B | $4.55B | $4.72B | $4.74B | $4.89B | $4.47B | $4.60B | $4.67B | $4.71B | $4.73B | · | $4.89B | $5.03B | $5.07B | · | $5.14B | |
| Other Non-current Assets | $1.08B | $1.07B | $1.10B | $1.02B | $1.04B | $1.07B | $1.10B | $1.17B | $1.25B | $1.20B | · | $1.21B | $1.16B | $1.12B | · | $1.06B | |
| Total Assets | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Accounts Payable | $352M | $361M | $303M | $315M | $349M | $301M | $195M | $322M | $342M | $370M | · | $320M | $355M | $397M | · | $334M | |
| Accrued Liabilities | · | · | $834M | · | · | · | $706M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.01B | $2.86B | $2.58B | $2.40B | $2.70B | $2.29B | $2.45B | $3.57B | $3.61B | $2.80B | · | $2.07B | $2.23B | $2.34B | · | $2.30B | |
| Capital Leases | · | · | $176M | · | · | · | $190M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $236M | $250M | $244M | · | · | · | $352M | · | · | $370M | · | $465M | $475M | $485M | · | $541M | |
| Other Non-current Liabilities | $639M | $631M | $626M | $806M | $879M | $909M | $744M | $1.03B | $1.21B | $577M | · | $632M | $642M | $637M | · | $609M | |
| Total Liabilities | $10.17B | $10.04B | $10.39B | $10.72B | $10.33B | $9.78B | $8.89B | $9.34B | $8.77B | $8.85B | · | $8.70B | $8.92B | $9.09B | · | $9.08B | |
| Long-term Debt | $7.48B | $7.47B | $7.52B | $8.11B | $7.57B | $7.18B | $6.20B | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Total Debt | $7.48B | $7.47B | · | $8.11B | $7.57B | $7.18B | · | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $11.96B | $11.80B | $11.61B | $11.52B | $11.34B | $11.23B | $11.10B | $10.90B | $10.70B | $10.51B | · | $10.01B | $9.90B | $9.74B | · | $9.74B | |
| Treasury Stock | $9.39B | $9.14B | $8.89B | $8.64B | $8.64B | $8.64B | $8.41B | $8.35B | $7.74B | $7.65B | · | $7.12B | $7.12B | $7.11B | · | $6.72B | |
| AOCI | $-164M | $-190M | $-206M | $-284M | $-284M | $-287M | $-263M | $-202M | $-195M | $-211M | · | $-186M | $-178M | $-178M | · | $-245M | |
| Stockholders' Equity | $12.62B | $12.67B | $12.70B | $12.76B | $12.53B | $12.40B | $12.47B | $12.37B | $12.74B | $12.60B | · | $12.51B | $12.37B | $12.15B | · | $12.24B | |
| Liabilities + Equity | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Shares Outstanding | 319,400,000 | 319,300,000 | 318,700,000 | 318,700,000 | 318,400,000 | 318,400,000 | 317,500,000 | 317,400,000 | 317,200,000 | 317,200,000 | 316,200,000 | 316,000,000 | 315,800,000 | 315,400,000 | 313,800,000 | 313,600,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $271M | $270M | $284M | $284M | $272M | $254M | $264M | $251M | $243M | $239M | $241M | $241M | $238M | $232M | $228M | $231M | |
| Stock-based Comp | $25M | $24M | $24M | $25M | $21M | $20M | $21M | $24M | $26M | $29M | $25M | $16M | $34M | $25M | $27M | $27M | |
| Amort. of Intangibles | $163M | $162M | $178M | $176M | $161M | $151M | $158M | $148M | $144M | $142M | $145M | $145M | $138M | $133M | $132M | $132M | |
| Other Non-cash | · | $-173M | · | · | · | $-73M | · | · | · | $-212M | · | · | · | $-182M | · | · | |
| Operating Cash Flow | $448M | $359M | $517M | $419M | $378M | $383M | $506M | $396M | $369M | $228M | $588M | $338M | $348M | $308M | $244M | $451M | |
| CapEx | $54M | $36M | $75M | $55M | $50M | $45M | $52M | $44M | $53M | $55M | $63M | $84M | $97M | $47M | $63M | $47M | |
| Investing Cash Flow | $-191M | $-159M | $-322M | $-163M | $-1.38B | $-106M | $-291M | $-155M | $-247M | $-195M | $-221M | $-166M | $-243M | $-149M | · | · | |
| Stock Repurchased | $251M | $250M | $250M | $0 | $7M | $230M | $72M | $596M | $86M | $114M | $410M | $0 | $14M | $268M | · | · | |
| Net Stock Activity | · | $-250M | · | · | · | $-230M | · | · | · | $-114M | · | · | · | $-268M | · | · | |
| Dividends Paid | $46M | $47M | $48M | $48M | $48M | $48M | $48M | $49M | $49M | $49M | $50M | $50M | $50M | $50M | $50M | $50M | |
| Financing Cash Flow | $-271M | $-369M | $-897M | $484M | $164M | $575M | $-241M | $-102M | $-92M | $-50M | $-251M | $-196M | $-109M | $-207M | · | · | |
| Net Change in Cash | $-14M | $-168M | $-701M | $736M | $-828M | $859M | $-44M | $149M | $27M | $-23M | $124M | $-28M | $-10M | $-46M | $-170M | $159M | |
| Free Cash Flow | · | $323M | · | · | · | $338M | · | · | · | $173M | · | · | · | $261M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 17.9% | · | 17.5% | 14.4% | 15.3% | · | 15.3% | 18.1% | 14.1% | · | 15.2% | 17.6% | 17.9% | · | 14.7% | |
| Net Margin | 9.1% | 11.4% | · | 11.5% | 7.4% | 9.5% | · | 13.7% | 12.5% | 9.1% | · | 9.3% | 11.2% | 12.7% | · | 11.6% | |
| Pretax Margin | 11.7% | 14.4% | · | 14.0% | 10.8% | 12.0% | · | 12.6% | 15.6% | 11.4% | · | 12.5% | 14.8% | 15.7% | · | 10.6% | |
| EBITDA Margin | 15.0% | 30.8% | · | 17.5% | 14.4% | 28.6% | · | 15.3% | 18.1% | 26.7% | · | 15.2% | 17.6% | 30.5% | · | 14.7% | |
| ROA | 0.87% | 1.1% | · | 1.0% | 0.69% | 0.83% | · | 1.2% | 1.1% | 0.81% | · | 0.76% | 0.98% | 1.1% | · | 0.86% | |
| ROE | 1.6% | 1.9% | · | 1.8% | 1.2% | 1.5% | · | 2.0% | 1.9% | 1.4% | · | 1.3% | 1.7% | 1.9% | · | 1.6% | |
| ROIC | 1.3% | 1.5% | · | 1.4% | 1.0% | 1.2% | · | 1.6% | 1.5% | 1.2% | · | 1.1% | 1.4% | 1.5% | · | 1.5% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.7 | · | 2.4 | 1.9 | 2.4 | · | 1.4 | 1.3 | 1.7 | · | 2.1 | 2.0 | 1.9 | · | 2.0 | |
| Quick Ratio | 0.7 | 0.8 | · | 1.2 | 0.8 | 1.3 | · | 0.6 | 0.5 | 0.7 | · | 0.8 | 0.8 | 0.7 | · | 0.8 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.4 | · | 1.3 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.52 | $39.69 | · | $40.03 | $39.34 | $38.93 | · | $38.99 | $40.17 | $39.72 | · | $39.59 | $39.18 | $38.52 | · | $39.05 | |
| Revenue / Share | $11.29 | $10.66 | · | $10.07 | $10.48 | $9.56 | · | $8.99 | $9.41 | $9.16 | · | $8.35 | $8.91 | $8.70 | · | $7.94 | |
| Cash Flow / Share | · | $1.84 | · | · | · | $1.92 | · | · | · | $1.11 | · | · | · | $1.46 | · | · | |
| Cash / Share | $1.28 | $1.33 | · | $4.06 | $1.75 | $4.35 | · | $1.79 | $1.32 | $1.24 | · | $0.92 | $1.01 | $1.05 | · | $1.74 | |
| Dividend / Share | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | |
| EPS (TTM) | $4.12 | $3.86 | · | $4.02 | $4.09 | $4.50 | · | $5.25 | $4.79 | $4.61 | · | $2.26 | $2.41 | $2.14 | · | $1.33 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.51B | $8.41B | · | $8.01B | $7.83B | $7.70B | · | $7.60B | $7.52B | $7.45B | · | $7.28B | $7.20B | $7.11B | · | $6.89B | |
| Net Income TTM | $807M | $761M | · | $805M | $823M | $913M | · | $1.08B | $997M | $964M | · | $474M | $506M | $450M | · | $278M | |
| Market Cap | $27.50B | $28.87B | · | $31.39B | $29.04B | $36.04B | · | $34.26B | $34.43B | $41.86B | · | $35.46B | $45.98B | $40.75B | · | $32.79B | |
| Enterprise Value | $34.57B | $35.92B | · | $38.21B | $36.06B | $41.83B | · | $40.15B | $39.84B | $47.27B | · | $40.65B | $51.37B | $46.21B | · | $37.96B | |
| P/E | 20.9 | 23.4 | · | 24.5 | 22.3 | 25.2 | · | 20.6 | 22.7 | 28.6 | · | 49.7 | 60.4 | 60.4 | · | 78.6 | |
| P/S | 3.2 | 3.4 | · | 3.9 | 3.7 | 4.7 | · | 4.5 | 4.6 | 5.6 | · | 4.9 | 6.4 | 5.7 | · | 4.8 | |
| P/B | 2.2 | 2.3 | · | 2.5 | 2.3 | 2.9 | · | 2.8 | 2.7 | 3.3 | · | 2.8 | 3.7 | 3.4 | · | 2.7 | |
| P / Cash Flow | · | 80.3 | · | · | · | 94.1 | · | · | · | 183.6 | · | · | · | 132.4 | · | · | |
| EV / Revenue | 4.1 | 4.3 | · | 4.8 | 4.6 | 5.4 | · | 5.3 | 5.3 | 6.3 | · | 5.6 | 7.1 | 6.5 | · | 5.5 | |
| Dividend Yield | 0.69% | 0.66% | · | 0.61% | 0.66% | 0.54% | · | 0.58% | 0.58% | 0.48% | · | 0.57% | 0.44% | 0.49% | · | 0.61% | |
| Earnings Yield | 4.8% | 4.3% | · | 4.1% | 4.5% | 4.0% | · | 4.9% | 4.4% | 3.5% | · | 2.0% | 1.7% | 1.7% | · | 1.3% | |
| Payout Ratio | · | 19.7% | · | · | · | 26.3% | · | · | · | 28.6% | · | · | · | 21.6% | · | · | |
| Annual Payout | $188M | $189M | · | $191M | $192M | $194M | · | $198M | $199M | $200M | · | $201M | $201M | $201M | · | $201M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Marża Operacyjna % | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% |
| Zysk netto | $705M | $904M | $1.02B | $231M | $402M |
| Rozwodniony EPS | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
| Wskaźnik bieżący | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 |
| Wskaźnik Szybkości | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B |
Właściciele instytucjonalni (13F) 976 emitentów · $18.6B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
976
Wartość posiadanych akcji
$18.6B
Nowe pozycje
89
Zamknięte pozycje
81
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 89 (-27 vs poprzedni kw.) | 81 (-21 vs poprzedni kw.) | 313 (+13 vs poprzedni kw.) | 303 (+4 vs poprzedni kw.) | +9.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2 111 657 991 | 23 483 741 | 11,35% | Akcje |
| Dodge & Cox | $2 076 898 436 | 24 124 735 | 11,17% | Akcje |
| BlackRock, Inc. | $1 344 282 175 | 15 614 847 | 7,23% | Akcje |
| HARRIS ASSOCIATES L P | $1 096 616 595 | 12 738 025 | 5,90% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 087 741 726 | 12 634 937 | 5,85% | Akcje |
| Capital International Investors | $1 048 887 329 | 12 183 614 | 5,64% | Akcje |
| STATE STREET CORP | $766 342 640 | 8 877 171 | 4,12% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $726 749 999 | 8 441 747 | 3,91% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $458 747 478 | 5 349 223 | 2,47% | Akcje |
| Invesco Ltd. | $342 626 146 | 3 979 860 | 1,84% | Akcje |
| PRIMECAP MANAGEMENT CO/CA/ | $328 577 983 | 3 816 680 | 1,77% | Akcje |
| VAN ECK ASSOCIATES CORP | $301 457 394 | 3 501 654 | 1,62% | Akcje |
| CITADEL ADVISORS LLC | $299 375 565 | 3 477 472 | 1,61% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $237 731 423 | 2 761 429 | 1,28% | Akcje |
| UBS Group AG | $237 489 165 | 2 758 615 | 1,28% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $236 270 951 | 2 744 463 | 1,27% | Akcje |
| MORGAN STANLEY | $223 102 705 | 2 591 503 | 1,20% | Akcje |
| BANK OF AMERICA CORP /DE/ | $187 480 282 | 2 177 724 | 1,01% | Akcje |
| NORTHERN TRUST CORP | $169 171 326 | 1 965 052 | 0,91% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $168 672 488 | 1 958 313 | 0,91% | Akcje |
| EQUITY INVESTMENT CORP | $144 748 296 | 1 681 360 | 0,78% | Akcje |
| NORGES BANK | $136 661 935 | 1 587 431 | 0,73% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $134 484 547 | 1 562 139 | 0,72% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $132 937 293 | 1 470 220 | 0,71% | Akcje |
| Legal & General Group Plc | $126 167 392 | 1 465 529 | 0,68% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $125 541 517 | 1 458 259 | 0,67% | Akcje |
| Vestal Point Capital, LP | $120 526 000 | 1 400 000 | 0,65% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $118 554 797 | 1 377 103 | 0,64% | Akcje |
| Holocene Advisors, LP | $101 367 617 | 1 177 461 | 0,54% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $99 065 937 | 1 150 725 | 0,53% | Akcje |
| Bank of New York Mellon Corp | $95 820 351 | 1 113 025 | 0,52% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $93 508 375 | 1 086 170 | 0,50% | Akcje |
| Camber Capital Management LP | $91 210 000 | 1 000 000 | 0,49% | Akcje |
| AMERIPRISE FINANCIAL INC | $89 620 025 | 1 040 975 | 0,48% | Akcje |
| GOLDMAN SACHS GROUP INC | $83 389 162 | 968 628 | 0,45% | Akcje |
| TORONTO DOMINION BANK | $81 590 162 | 947 731 | 0,44% | Akcje |
| Woodline Partners LP | $81 122 607 | 942 300 | 0,44% | Akcje |
| DEUTSCHE BANK AG\ | $79 508 592 | 923 552 | 0,43% | Akcje |
| Point72 Asset Management, L.P. | $75 746 373 | 879 851 | 0,41% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $74 568 500 | 866 170 | 0,40% | Akcje |
| JPMORGAN CHASE & CO | $74 444 065 | 815 914 | 0,40% | Akcje |
| Sound Shore Management Inc /CT/ | $68 407 286 | 794 602 | 0,37% | Akcje |
| CAUSEWAY CAPITAL MANAGEMENT LLC | $67 908 650 | 788 810 | 0,37% | Akcje |
| Quantinno Capital Management LP | $62 169 005 | 722 139 | 0,33% | Akcje |
| Amundi | $61 922 729 | 719 279 | 0,33% | Akcje |
| Boston Partners | $61 088 392 | 709 202 | 0,33% | Akcje |
| Meridiem Capital Partners LP | $54 973 200 | 638 555 | 0,30% | Akcje |
| SHAPIRO CAPITAL MANAGEMENT LLC | $52 119 833 | 605 411 | 0,28% | Akcje |
| BANK OF MONTREAL /CAN/ | $49 368 266 | 573 449 | 0,27% | Akcje |
| Magellan Asset Management Ltd | $49 106 511 | 570 409 | 0,26% | Akcje |
Aktywiści i właściciele 5%+ 6 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc., Honey Badger Merger Sub, Inc. | 15 lipca 2025 | 27,00% | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| KKR Biomet LLC, KKR 2006 Fund L.P., OPERF Co-Investment LLC, KKR PEI Investments, L.P., 8 North America Investor L.P., KKR Partners III, L.P., KKR Associates 2006 LP, KKR 2006 GP LLC, KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Associates 8 NA L.P., KKR 8 NA Limited, KKR III GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts ×3 zgłoszenia | 16 czerwca 2016 | · | Pierwotne zgłoszenie | · | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×3 zgłoszenia | 16 czerwca 2016 | · | Pierwotne zgłoszenie | Struktura kapitałowa | SEC |
| Blackstone Capital Partners V, L.P., Blackstone Capital Partners V-AC L.P., BCP V-S L.P., Blackstone Family Investment Partnership V L.P., Blackstone Family Investment Partnership V-SMD L.P., Blackstone Participation Partnership V L.P., BCP V Co-Investors L.P., Blackstone Management Associates V L.L.C., BMA V L.L.C., BCP V Side-By-Side GP L.L.C., Blackstone Family GP L.L.C., Blackstone Holdings III L.P., Blackstone Holdings III GP L.P., Blackstone Holdings III GP Management L.L.C., The Blackstone Group L.P., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 zgłoszenia | 12 lutego 2016 | · | Pierwotne zgłoszenie | · | SEC |
| LVB Acquisition Holding, LLC ×2 zgłoszenia | 9 lutego 2016 | · | Pierwotne zgłoszenie | · | SEC |
| Zimmer Holdings, Inc., Zimmer, Inc., Zimmer CEP USA Holding Co. ×3 zgłoszenia | 10 sierpnia 2006 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 62 insiderów · 38 dyrektorzy generalni · 24 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ivan Tornos | Chairman, President and CEO | 6 marca 2026 M | 83 191 | 0 | 0 | $0 |
| Bryan C Hanson | President and CEO | 6 marca 2023 A | 102 797 | 0 | 0 | $0 |
| John Raymond Elliott | Chairman, Pres. & CEO | 12 lutego 2007 M | 62 751 | 0 | 0 | $0 |
| Suketu Upadhyay | Exec VP, CFO | 6 marca 2026 M | 69 485 | 0 | 0 | $0 |
| Florin Daniel P | Exec. VP, CFO | 8 maja 2019 G | 25 471 | 0 | 0 | $0 |
| James T Crines | EVP, Finance and CFO | 19 marca 2015 M | 56 313 | 0 | 0 | $0 |
| Chintan Desai | President, APAC | 3 sierpnia 2026 A | · | 0 | 0 | $0 |
| Sang Yi | Group President, Asia Pacific | 29 maja 2026 S | 27 251 | 0 | 3 | $-509 706 |
| Mark Bezjak | President, Americas | 6 marca 2025 M | 13 134 | 0 | 0 | $0 |
| Didier Deltort | President, EMEA | 26 lutego 2021 M | 4 619 | 0 | 0 | $0 |
| Aure Bruneau | Group President | 11 listopada 2019 M | 757 | 0 | 0 | $0 |
| Robert D. Delp | President, Americas | 20 marca 2018 A | · | 0 | 0 | $0 |
| David A. Nolan Jr. | Group President | 20 marca 2018 A | 9 102 | 0 | 0 | $0 |
| Daniel E. Williamson | Group President | 20 marca 2018 A | 2 000 | 0 | 0 | $0 |
| Adam Rudolph Johnson | Group President | 24 czerwca 2017 M | 11 093 | 0 | 0 | $0 |
| Stuart G. Kleopfer | President, Americas | 23 sierpnia 2016 S | 3 000 | 0 | 0 | $0 |
| Stephen H L Ooi | President, Asia Pacific | 19 marca 2015 M | 45 411 | 0 | 0 | $0 |
| Joseph A. Cucolo | President, Americas | 1 października 2014 M | 11 226 | 0 | 0 | $0 |
| Jon E Kramer | President, U.S. Sales | 12 grudnia 2008 M | 4 461 | 0 | 0 | $0 |
| Kevin R Thornal | Grp Pres-Global Business | 11 września 2026 S | 0 | 0 | 1 | $-528 978 |
| Chad F Phipps | Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary | 4 września 2026 S | 65 231 | 0 | 1 | $-295 050 |
| Jehanzeb Noor | Senior Vice President, Chief Strategy, Innovation & Business Development Officer | 1 czerwca 2026 A | 5 151 | 0 | 0 | $0 |
| Paul A Stellato | VP, Controller, CAO | 1 maja 2026 A | 5 582 | 0 | 0 | $0 |
| Lori Winkler | SVP and CHRO | 12 marca 2026 S | 10 224 | 0 | 1 | $-250 849 |
| Wilfred Van Zuilen | Group Pres, EMEA | 6 marca 2026 M | 30 991 | 0 | 0 | $0 |
| Rachel Ellingson | Chief Administrative Officer | 20 lutego 2025 M | 11 906 | 0 | 0 | $0 |
| Derek M Davis | Interim Controller & CAO | 1 marca 2022 A | 6 809 | 0 | 0 | $0 |
| Carrie Ann Nichol | VP, Controller & CAO | 1 października 2021 M | 338 | 0 | 0 | $0 |
| Tony W. Collins | VP, Controller and CAO | 31 lipca 2018 M | 368 | 0 | 0 | $0 |
| Katarzyna Mazur-Hofsaess | Pres., Eur., M. East & Afr. | 22 maja 2018 M | 16 682 | 0 | 0 | $0 |
| Jeffery A Mccaulley | Pres - Zimmer Reconstructive | 8 stycznia 2014 M | 5 211 | 0 | 0 | $0 |
| Jeffrey B Paulsen | Group Pres., Global Businesses | 16 marca 2013 M | 6 095 | 0 | 0 | $0 |
| Cheryl R Blanchard | Sr. VP, Chief Scientific Off. | 19 marca 2012 A | 18 357 | 0 | 0 | $0 |
| Mark C Throdahl | Group Pres - Global Business | 12 czerwca 2009 D | 844 | 0 | 0 | $0 |
| Sheryl L Conley | Group Pres., Americas & Mktg. | 12 lutego 2008 A | 2 559 | 0 | 0 | $0 |
| Sam R Leno | EVP | 4 maja 2007 D | 27 513 | 0 | 0 | $0 |
| Richard Fritschi | Pres. Zimmer Europe & Austral. | 18 stycznia 2005 A | · | 0 | 0 | $0 |
| Bruce Edward Peterson | Chairman, Zimmer Americas | 17 marca 2004 M | 17 975 | 0 | 0 | $0 |
| Louis Shapiro | Dyrektor | 30 września 2026 A | · | 0 | 0 | $0 |
| Devdatt Kurdikar | Dyrektor | 30 września 2026 A | · | 0 | 0 | $0 |
| Sreelakshmi Kolli | Dyrektor | 30 września 2026 A | 1 000 | 0 | 0 | $0 |
| Maria Teresa Hilado | Dyrektor | 30 września 2026 A | 1 650 | 0 | 0 | $0 |
| Michael J. Farrell | Dyrektor | 30 września 2026 A | 2 000 | 0 | 0 | $0 |
| Robert Hagemann | Dyrektor | 30 września 2026 A | 4 000 | 0 | 0 | $0 |
| HIGGINS ARTHUR J | Dyrektor | 30 września 2026 A | 3 400 | 0 | 0 | $0 |
| Syed A. Jafry | Dyrektor | 22 maja 2026 A | 4 060 | 0 | 0 | $0 |
| Betsy J Bernard | Dyrektor | 22 maja 2026 A | 5 271 | 0 | 0 | $0 |
| Christopher B Begley | Dyrektor | 31 marca 2025 A | 3 540 | 0 | 0 | $0 |
| Michael W Michelson | Dyrektor | 10 maja 2024 A | 3 385 | 0 | 0 | $0 |
| Gail Boudreaux | Dyrektor | 31 marca 2021 A | 2 095 | 0 | 0 | $0 |
| Larry C Glasscock | Dyrektor | 8 maja 2020 A | 10 861 | 0 | 0 | $0 |
| Jeffrey K. Rhodes | Dyrektor | 31 marca 2018 A | · | 0 | 0 | $0 |
| Cecil B Pickett | Dyrektor | 12 maja 2017 A | · | 0 | 0 | $0 |
| Paul Bisaro | Dyrektor | 31 marca 2017 A | · | 0 | 0 | $0 |
| John L Mcgoldrick | Dyrektor | 7 maja 2013 A | 11 332 | 0 | 0 | $0 |
| Marc N Casper | Dyrektor | 31 marca 2013 A | · | 0 | 0 | $0 |
| Augustus A White | Dyrektor | 3 maja 2010 A | 0 | 0 | 0 | $0 |
| Stuart Essig | Dyrektor | 5 maja 2008 A | · | 0 | 0 | $0 |
| Regina E Herzlinger | Dyrektor | 2 maja 2005 A | 40 | 0 | 0 | $0 |
| David C Dvorak | · | 27 kwietnia 2017 M | 294 555 | 0 | 0 | $0 |
| LVB Acquisition Holding, LLC | · | 4 lutego 2016 J | 0 | 0 | 0 | $0 |
| Bruno A Melzi | · | 16 marca 2013 M | 11 005 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 119 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHI · iShares Trust | 2,69% | 924 883 SH | 11 września 2026 | Dziennie |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,47% | 275 654 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,54% | 152 036 SH | 2 października 2026 | Dziennie |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,94% | 139 642 NS | 31 lipca 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,94% | 4 287 NS | 31 lipca 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,49% | 81 838 NS | 31 lipca 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,47% | 5 916 NS | 31 lipca 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 8 435 NS | 31 lipca 2026 | N-PORT |
| SOVF · Elevation Series Trust | 0,41% | 3 781 NS | 31 lipca 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,40% | 2 152 NS | 31 lipca 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,34% | 64 683 SH | 2 października 2026 | Dziennie |
| IYH · iShares Trust | 0,29% | 113 463 SH | 11 września 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,26% | 91 889 NS | 31 lipca 2026 | N-PORT |
| IMCV · iShares Trust | 0,25% | 31 505 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,25% | 581 880 SH | 19 sierpnia 2026 | Dziennie |
| REVS · Columbia ETF Trust I | 0,24% | 8 508 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 0,23% | 101 995 SH | 11 września 2026 | Dziennie |
| SIZE · iShares Trust | 0,21% | 9 696 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,21% | 3 807 NS | 31 lipca 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,19% | 6 205 NS | 31 lipca 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 2 063 000 SH | 2 października 2026 | Dziennie |
| EUSA · iShares, Inc. | 0,19% | 38 732 SH | 11 września 2026 | Dziennie |
| VLUE · iShares Trust | 0,18% | 191 362 SH | 11 września 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,18% | 1 408 631 SH | 19 sierpnia 2026 | Dziennie |
| IWS · iShares Trust | 0,18% | 289 171 SH | 11 września 2026 | Dziennie |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,16% | 220 000 | 2 października 2026 | Dziennie |
| RECS · Columbia ETF Trust I | 0,16% | 96 586 NS | 31 lipca 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 13 402 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,15% | 15 020 SH | 19 sierpnia 2026 | Dziennie |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,15% | 4 099 000 | 2 października 2026 | Dziennie |
| VOE · VANGUARD INDEX FUNDS | 0,14% | 621 372 SH | 19 sierpnia 2026 | Dziennie |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,14% | 6 247 000 | 1 października 2026 | Dziennie |
| IWR · iShares Trust | 0,13% | 792 254 SH | 11 września 2026 | Dziennie |
| IMCB · iShares Trust | 0,12% | 22 655 SH | 11 września 2026 | Dziennie |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 4 049 000 | 1 października 2026 | Dziennie |
| XOEF · iShares Trust | 0,10% | 248 SH | 11 września 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2 218 373 SH | 19 sierpnia 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 8 178 SH | 2 października 2026 | Dziennie |
| CATH · Global X Funds | 0,09% | 11 989 NS | 31 lipca 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,08% | 2 097 251 SH | 19 sierpnia 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 8 286 SH | 2 października 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,07% | 118 337 NS | 31 lipca 2026 | N-PORT |
| USXF · iShares Trust | 0,07% | 11 458 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 70 147 SH | 2 października 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,06% | 14 595 NS | 31 lipca 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,06% | 44 339 SH | 19 sierpnia 2026 | Dziennie |
| IVE · iShares Trust | 0,06% | 321 014 SH | 11 września 2026 | Dziennie |
| IUSV · iShares Trust | 0,06% | 168 895 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,06% | 3 302 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,06% | 284 411 NS | 31 lipca 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,06% | 1 943 NS | 31 lipca 2026 | N-PORT |
| CHRI · Global X Funds | 0,06% | 47 NS | 31 lipca 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 7 599 SH | 11 września 2026 | Dziennie |
| SUSL · iShares Trust | 0,05% | 6 763 SH | 11 września 2026 | Dziennie |
| DSI · iShares Trust | 0,05% | 29 825 SH | 11 września 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 116 793 SH | 19 sierpnia 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,05% | 17 680 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,05% | 429 649 SH | 11 września 2026 | Dziennie |
| EGLE · Global X Funds | 0,04% | 10 NS | 31 lipca 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,04% | 5 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,04% | 44 794 SH | 2 października 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,03% | 24 552 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,03% | 45 016 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 226 NS | 31 lipca 2026 | N-PORT |
| TOPC · iShares Trust | 0,03% | 117 SH | 11 września 2026 | Dziennie |
| XCLR · Global X Funds | 0,03% | 12 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,03% | 163 NS | 31 lipca 2026 | N-PORT |
| XVV · iShares Trust | 0,03% | 2 222 SH | 11 września 2026 | Dziennie |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 5 778 SH | 2 października 2026 | Dziennie |
| VOO · VANGUARD INDEX FUNDS | 0,03% | 5 022 961 SH | 19 sierpnia 2026 | Dziennie |
| VTV · VANGUARD INDEX FUNDS | 0,03% | 920 066 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,03% | 43 771 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,03% | 921 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,03% | 17 261 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,03% | 10 147 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,03% | 10 046 NS | 31 lipca 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 26 677 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,03% | 3 273 NS | 31 lipca 2026 | N-PORT |
| ILCB · iShares Trust | 0,03% | 3 851 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,03% | 60 829 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,03% | 2 438 768 SH | 11 września 2026 | Dziennie |
| XTR · Global X Funds | 0,03% | 14 NS | 31 lipca 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 1 142 SH | 2 października 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,03% | 730 NS | 31 lipca 2026 | N-PORT |
| IYY · iShares Trust | 0,03% | 8 407 SH | 11 września 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 33 488 SH | 2 października 2026 | Dziennie |
| IWB · iShares Trust | 0,03% | 133 637 SH | 11 września 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,03% | 4 637 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,03% | 54 548 SH | 11 września 2026 | Dziennie |
| USCL · iShares Trust | 0,03% | 7 635 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,02% | 251 793 SH | 11 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,02% | 1 351 NS | 31 lipca 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,02% | 350 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,02% | 545 SH | 11 września 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,02% | 15 123 NS | 31 lipca 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,02% | 143 SH | 2 października 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 6 142 505 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31 872 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 16 297 SH | 19 sierpnia 2026 | Dziennie |
| URTH · iShares, Inc. | 0,02% | 17 242 SH | 11 września 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,02% | 12 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 4 266 NS | 31 lipca 2026 | N-PORT |
| ACWI · iShares Trust | 0,02% | 64 570 SH | 11 września 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,02% | 23 873 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 5 624 SH | 2 października 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,01% | 113 321 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 168 446 SH | 19 sierpnia 2026 | Dziennie |
| DYNF · BlackRock ETF Trust | 0,00% | 80 SH | 2 września 2026 | Dziennie |
| FTLS · First Trust Exchange-Traded Fund III | -0,18% | -46 926 NS | 31 lipca 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| VCEB · VANGUARD WORLD FUND | · | · | 30 lipca 2026 | Dziennie |
ZBH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 33 analityków
TRZYMAJ
Średni cel
$106.00
+15,8%
3 9,1%
Mocne kupno
8 24,2%
Kup
22 66,7%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
21 analityków · 2026-10-06Średnia cel $107.57 +17,5%
← Poniżej wszystkich celów
Aktualna cena $91.57
Niski$93.00
Średnia$107.57
Wysoki$130.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 5, 2026